Literature DB >> 16543350

LIFT study is discontinued.

Steven R Cummings.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16543350      PMCID： PMC1403233          DOI： 10.1136/bmj.332.7542.667

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  LIFT study to continue as planned.

Authors:  Diederick E Grobbee
Journal:  BMJ       Date:  2005-10-08
  1 in total
  6 in total

1.  Still waiting and searching for answers.

Authors:  Emilio Maestri; Susanna Maltoni; Vittorio Basevi; Annamaria Marata; Nicola Magrini
Journal:  BMJ       Date:  2008-01-05

Review 2.  Postmenopausal tibolone therapy: biologic principles and applied clinical practice.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2007-01-03

3.  Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.

Authors:  Joanna Watson; Lesley Wise; Jane Green
Journal:  Eur J Clin Pharmacol       Date:  2007-06-28       Impact factor: 2.953

4.  Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women.

Authors:  P D Delmas; S R Davis; J Hensen; S Adami; S van Os; E A Nijland
Journal:  Osteoporos Int       Date:  2008-02-07       Impact factor: 4.507

Review 5.  Short-term and long-term effects of tibolone in postmenopausal women.

Authors:  Giulio Formoso; Enrica Perrone; Susanna Maltoni; Sara Balduzzi; Jack Wilkinson; Vittorio Basevi; Anna Maria Marata; Nicola Magrini; Roberto D'Amico; Chiara Bassi; Emilio Maestri
Journal:  Cochrane Database Syst Rev       Date:  2016-10-12

6.  Efficacy of tibolone and raloxifene for the maintenance of skeletal muscle strength, bone mineral density, balance, body composition, cognitive function, mood/depression, anxiety and quality of life/well-being in late postmenopausal women >/= 70 years: study design of a randomized, double-blind, double-dummy, placebo-controlled, single-center trial.

Authors:  Didy E Jacobsen; Monique M Samson; Yvonne T van der Schouw; Diederick E Grobbee; Harald J J Verhaar
Journal:  Trials       Date:  2008-06-05       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.